Immunocore to report second quarter 2026 financial results and host call on August 6, 2026
Globe Newswire•30/07/2026•07:00 ET
0
Whiz Insights
Immunocore to report second quarter 2026 financial results and host call on August 6, 2026
(OXFORDSHIRE, England & RADNOR, PA & GAITHERSBURG, MD, US, 30 July 2026) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”) (link), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report financial results for the second quarter ended June 30, 2026 on Thursday, August 6, 2026.
Get started
Create a free account to read the full story.